Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Harding
Joseph Mikhael

Blood

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood|January 2, 2025
Down with dex!Susan Harding, Joseph Mikhael
Blood|December 24, 2016
Pee no more? Urine light chains down the drainJoseph Mikhael
Blood|August 30, 2011
Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaRobert Griffiths, Joseph Mikhael, Michelle Gleeson, et al.
Blood|December 31, 2010
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemiaMark D Danese, Robert I Griffiths, Michelle Gleeson, et al.
Blood|March 14, 2019
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myelomaJoseph Mikhael, Paul Richardson, Saad Z Usmani, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Blood|October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myelomaShaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Blood|January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 studyPaul G Richardson, David S Siegel, Ravi Vij, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Blood|October 6, 2016
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomibShaji K Kumar, Betsy R LaPlant, Craig B Reeder, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|January 2, 2025
Down with dex!Susan Harding, Joseph Mikhael
Blood|December 24, 2016
Pee no more? Urine light chains down the drainJoseph Mikhael
Blood|August 30, 2011
Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaRobert Griffiths, Joseph Mikhael, Michelle Gleeson, et al.
Blood|December 31, 2010
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemiaMark D Danese, Robert I Griffiths, Michelle Gleeson, et al.
Blood|March 14, 2019
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myelomaJoseph Mikhael, Paul Richardson, Saad Z Usmani, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Blood|October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myelomaShaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Blood|January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 studyPaul G Richardson, David S Siegel, Ravi Vij, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Blood|October 6, 2016
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomibShaji K Kumar, Betsy R LaPlant, Craig B Reeder, et al.
Pageof 1